TITLE:
Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer

CONDITION:
Thyroid Cancer

INTERVENTION:
ZD6474 (vandetanib)

SUMMARY:

      The purpose of this open label, two stage, phase II study is to evaluate the efficacy and
      tolerability of ZD6474 in patients with locally advanced or metastatic hereditary medullary
      thyroid carcinoma.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 130 Years
Criteria:

        Inclusion Criteria:

          -  Locally advanced or hereditary medullary thyroid cancer

          -  Signed informed consent

          -  One or more measurable lesions

        Exclusion Criteria:

          -  Brain metastases or spinal cord compression

          -  Specific laboratory ranges

          -  Specific heart problems

          -  Prior chemotherapy and/or radiation therapy

          -  Participation in other trials within 30 days
      
